Skip to content
MedsAcross

Medicine

Frovatriptan 2.5 mg tablet

Frovatriptan · Oral
Available on requestPrescription onlyUS FDAGeneric name

Frovatriptan 2.5 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Frovatriptan
Brand
Sold under the generic name
Strength
2.5 mg
Dosage form
Tablet
Route
Oral
Packs
1 blister pack, 9 tablets and 1 more
Manufacturers
Glenmark PharmaceuticalsIndiaAmneal Pharmaceuticals NYIngenus PharmaceuticalsLeading Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N02CC07 Frovatriptan
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
11 March 2016
Identifiers
RxCUI 349462DailyMed set ID 94b996dc-ddc4-41ce-9a9f-3d91cb187473, 03a58215-dba7-4f63-8b98-d74d054a574a, 92c91060-c06e-4a8a-b586-a3fb25c33433 +1NDC 69238-1539, 68462-694, 50742-299 +1Application ANDA211292, ANDA204730, ANDA213891 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 blister pack in 1 carton / 9 tablet, film coated in 1 blister pack68462-694-97Glenmark PharmaceuticalsIndia11 March 2016
1 blister pack in 1 carton / 9 tablet, film coated in 1 blister pack69238-1539-9Amneal Pharmaceuticals NY13 November 2018
1 blister pack in 1 carton / 9 tablet, film coated in 1 blister pack50742-299-09Ingenus Pharmaceuticals22 July 2022
9 tablet, film coated in 1 carton69315-157-13Leading Pharma28 February 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 November 2001Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Frovatriptan is a serotonin-1b and serotonin-1d receptor agonist indicated for the acute treatment of migraine with or without aura in adults, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Frovatriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Frovatriptan

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Frovatriptan 2.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.